← Back to all trials
Not Yet Recruiting
NCT05627505
Diagnostic and Prognostic Value of Lung Microbiota in Early Lung Infection After Lung Transplantation
Conditions: Pneumonia
Sex: All
Ages: 18 Years – N/A
Enrollment: 80
Sponsor: Qingyuan Zhan
Summary
The present study is a prospective case-control study.
Patients were enrolled post lung transplantation and alveolar lavage fluid was obtained within 48 hours of the patient's surgery, divided into aliquots and subjected to macrogenomic sequencing, routine microbiological testing and cytokine testing.
Patients were divided into pulmonary infection and non-pulmonary infection groups based on whether they had a co-infection at the time of sampling.
Pulmonary infection was used as the primary study endpoint.
To describe and compare the characteristics of the lung microbiota in the two groups and to determine whether variation in the lung microbiota could predict the development of lung infection and prognosis in patients in the early post-transplant period.
Eligibility Criteria
Inclusion Criteria:Patients admitted to the ICU for lung transplantation; consent for bronchoscopy; informed consent signed by the patient or their representative.Exclusion Criteria:Patients admitted to ICU for other serious illnesses; patients more than 48 hours after lung transplantation; patients predicted to die within 48 hours; participation in other clinical studies; failure to sign an informed consent form.
Source: ClinicalTrials.gov (NCT05627505). StuddyBuddy aggregates publicly available trial information.